info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Esomar23 wcrc
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Avascular Necrosis Market Analysis

ID: MRFR//4673-CR | 539 Pages | Author: Kinjoll Dey| June 2018

In-depth Analysis of Avascular Necrosis Market Industry Landscape

People are becoming more aware of avascular necrosis (AVN) because it's becoming more common. In the United States, about 15,000 cases of AVN pop up each year. It's most common in folks between 30 and 50 years old, and it affects males more than females. When kids get it in their femur bone, it's called Legg-Calvé-Perthes syndrome. Taking certain drugs during treatments like chemotherapy, radiation therapy, high-dose steroids, or organ transplants can also lead to osteonecrosis. People with HIV, cancer, gout, Gaucher's disease, and other conditions are also prone to it.

A company presentation by Bone Therapeutics in 2017 mentioned around 170,000 people in the US, Europe, and Japan were dealing with osteonecrosis. More doctors and patients are learning about osteonecrosis, which helps the market for treating it grow. New treatments like stem cell-based therapy and gene therapy are also expected to boost this market.

For osteonecrosis, surgeries are becoming more popular. About 20,000 hip replacement surgeries are done yearly in the US because of osteonecrosis, as reported by the American Academy of Orthopedic Surgeons. While medicines like pain relievers and cholesterol-lowering drugs help control symptoms, they don't cure the condition. That's why surgeries are often needed. Some common surgeries include core decompression to increase blood flow to the bones, joint replacement, bone grafts, and osteotomy to reduce joint stress.

Stanford University is looking into a project to evaluate osteonecrosis before and after decompression surgery using MRI enhanced by ferumoxytol. This helps better detect and track transplanted bone marrow cells. This project is in a phase 4 clinical trial and is expected to make surgical procedures more effective. These kinds of improvements in surgical treatments that work better are likely to push the osteonecrosis treatment market forward.

Avascular necrosis (AVN) is getting more attention because it's becoming more common. In the US alone, there are around 15,000 new cases of AVN every year. It mainly affects people between 30 to 50 years old, and it tends to affect more males than females. When kids have it in their thigh bone, it's called Legg-Calvé-Perthes syndrome. Using certain drugs during treatments like chemotherapy, radiation therapy, high-dose steroids, or organ transplants can also lead to osteonecrosis. People with conditions like HIV, cancer, gout, Gaucher's disease, and others are also at risk.

A presentation by Bone Therapeutics in 2017 mentioned that about 170,000 people in the US, Europe, and Japan were dealing with osteonecrosis. More doctors and patients are learning about osteonecrosis, which helps the market for treating it grow. New treatments like using stem cells or gene therapy are expected to make this market even bigger.

Surgeries for osteonecrosis are getting more popular. The American Academy of Orthopedic Surgeons says there are about 20,000 hip replacement surgeries every year in the US because of osteonecrosis. While medicines like pain relievers and drugs that lower cholesterol can help control the symptoms, they can't cure the condition. That's why surgeries are often needed. Some common surgeries include doing a core decompression to increase blood flow to the bones, replacing the joint, bone grafts, and osteotomy to reduce stress on the joint.

Stanford University is working on a project to check osteonecrosis before and after decompression surgery using a special kind of MRI that's enhanced by ferumoxytol. This helps find and track transplanted bone marrow cells better. This project is in a phase 4 clinical trial and is expected to make surgical procedures work even better. When surgical treatments improve like this, it's likely to help the market for osteonecrosis treatments to grow even more.

Covered Aspects:
Report Attribute/Metric Details
Segment Outlook Type, Treatment End User, and Region
Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.